CTEPH Treatment Options
Have you recently had a pulmonary embolism (PE)? Well this live webinar is for you! In a small number of patients who’ve had blood clots in their lungs—a pulmonary embolism—the clots don’t go away, and you can be at risk of developing CTEPH (Chronic Thromboembolic Pulmonary Hypertension), which can be deadly, but curable!
Sign up for this free live webinar & interactive QA session on June 14th, from 7:00pm – 8:00pm EST, to learn more about what can be done for patients with CTEPH, and what happens after a CTEPH diagnosis is made.
Webinar Hosts:
Todd Bull, MD
University of Colorado Hospital
Todd Bull, MD, is a professor of Medicine within the division of Pulmonary Sciences and Critical Care Medicine and the Division of Cardiology at the University of Colorado.
Dr. Bull divides his time between the out-patient clinic, in-patient wards, the cardiac catheterization laboratory and the medical intensive care unit. He has an active research laboratory and is involved in a number of clinical trials investigating novel therapeutic agents in the treatment of PAH and pulmonary embolism.
Richard N. Channick, MD
UCLA Medical Center
Richard Channick, MD, is Professor of Medicine and Saul Brandman Endowed Chair of Pulmonary Arterial Hypertension at David Geffen School of Medicine at UCLA
Dr. Channick has published over 200 original articles, chapters and reviews focused on all aspects of pulmonary hypertension and pulmonary embolism. He serves on national and international leadership committees including the American Thoracic Society Pulmonary Circulation Program Committee and the American College of Chest Physicians Pulmonary Vascular Disease Network steering committee.
Interested in more? Check out the rest of our series!
CTEPH & YOU – Part 1: CTEPH 101: Am I at Risk?! This webinar covers what Chronic Thromboembolic Pulmonary Hypertension (CTEPH) is and who is at risk of developing it.
CTEPH & YOU – Part 2: How is CTEPH Diagnosed? This webinar covers how CTEPH and CTEPD are diagnosed, and signs & symptoms for patients to know and to be aware of.
Thank you to our program sponsor, Johnson & Johnson Health Care Systems.